1	Activation	Activation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	primary	primary	_	_	_	_	_	_	_
4	human	human	_	_	_	_	_	_	_
5	T-lymphocytes	t-lymphocyte	_	_	_	_	_	_	_
6	through	through	_	_	_	_	_	_	_
7	CD2	cd2	_	_	_	_	_	_	_
8	plus	plus	_	_	_	_	_	_	_
9	CD28	cd28	_	_	_	_	_	_	_
10	adhesion	adhesion	_	_	_	_	_	_	_
11	molecules	molecule	_	_	_	_	_	_	_
12	induces	induce	_	_	_	_	_	_	_
13	long-term	long-term	_	_	_	_	_	_	_
14	nuclear	nuclear	_	_	_	_	_	_	_
15	expression	expression	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	NF-kappa	NF-kappa	_	_	_	_	_	_	_
18	B.	B.	_	_	_	_	_	_	_
19	Stimulation	stimulation	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	highly	highly	_	_	_	_	_	_	_
22	purified	purify	_	_	_	_	_	_	_
23	human	human	_	_	_	_	_	_	_
24	T-cells	t-cell	_	_	_	_	_	_	_
25	via	via	_	_	_	_	_	_	_
26	CD2	cd2	_	_	_	_	_	_	_
27	and	and	_	_	_	_	_	_	_
28	CD28	cd28	_	_	_	_	_	_	_
29	adhesion	adhesion	_	_	_	_	_	_	_
30	molecules	molecule	_	_	_	_	_	_	_
31	induces	induce	_	_	_	_	_	_	_
32	and	and	_	_	_	_	_	_	_
33	maintains	maintain	_	_	_	_	_	_	_
34	proliferation	proliferation	_	_	_	_	_	_	_
35	for	for	_	_	_	_	_	_	_
36	more	more	_	_	_	_	_	_	_
37	than	than	_	_	_	_	_	_	_
38	3	3	_	_	_	_	_	_	_
39	weeks	week	_	_	_	_	_	_	_
40	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	potent	potent	_	_	_	_	_	_	_
3	interleukin	interleukin	_	_	_	_	_	_	_
4	2	2	_	_	_	_	_	_	_
5	(	(	_	_	_	_	_	_	_
6	IL-2)-dependent	il-2)-dependent	_	_	_	_	_	_	_
7	activation	activation	_	_	_	_	_	_	_
8	does	do	_	_	_	_	_	_	_
9	not	not	_	_	_	_	_	_	_
10	require	require	_	_	_	_	_	_	_
11	monocytes	monocyte	_	_	_	_	_	_	_
12	or	or	_	_	_	_	_	_	_
13	accessory	accessory	_	_	_	_	_	_	_
14	cells	cell	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	Long-lasting	long-lasting	_	_	_	_	_	_	_
2	IL-2	il-2	_	_	_	_	_	_	_
3	receptivity	receptivity	_	_	_	_	_	_	_
4	is	be	_	_	_	_	_	_	_
5	associated	associate	_	_	_	_	_	_	_
6	with	with	_	_	_	_	_	_	_
7	high-level	high-level	_	_	_	_	_	_	_
8	expression	expression	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	inducible	inducible	_	_	_	_	_	_	_
12	IL-2	il-2	_	_	_	_	_	_	_
13	receptor	receptor	_	_	_	_	_	_	_
14	alpha	alpha	_	_	_	_	_	_	_
15	chain	chain	_	_	_	_	_	_	_
16	(	(	_	_	_	_	_	_	_
17	IL-2R	IL-2R	_	_	_	_	_	_	_
18	alpha	alpha	_	_	_	_	_	_	_
19	)	)	_	_	_	_	_	_	_
20	gene	gene	_	_	_	_	_	_	_
21	that	that	_	_	_	_	_	_	_
22	is	be	_	_	_	_	_	_	_
23	regulated	regulate	_	_	_	_	_	_	_
24	at	at	_	_	_	_	_	_	_
25	both	both	_	_	_	_	_	_	_
26	transcriptional	transcriptional	_	_	_	_	_	_	_
27	and	and	_	_	_	_	_	_	_
28	posttranscriptional	posttranscriptional	_	_	_	_	_	_	_
29	levels	level	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	Increase	increase	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	IL-2R	IL-2R	_	_	_	_	_	_	_
4	alpha	alpha	_	_	_	_	_	_	_
5	gene	gene	_	_	_	_	_	_	_
6	transcription	transcription	_	_	_	_	_	_	_
7	involves	involve	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	enhanced	enhance	_	_	_	_	_	_	_
10	binding	binding	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	transcription	transcription	_	_	_	_	_	_	_
14	factor	factor	_	_	_	_	_	_	_
15	NF-kappa	NF-kappa	_	_	_	_	_	_	_
16	B	B	_	_	_	_	_	_	_
17	to	to	_	_	_	_	_	_	_
18	its	its	_	_	_	_	_	_	_
19	consensus	consensus	_	_	_	_	_	_	_
20	sequence	sequence	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	5â€™-regulatory	5'-regulatory	_	_	_	_	_	_	_
24	region	region	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	IL-2R	IL-2R	_	_	_	_	_	_	_
28	alpha	alpha	_	_	_	_	_	_	_
29	gene	gene	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	To	to	_	_	_	_	_	_	_
2	dissect	dissect	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	molecular	molecular	_	_	_	_	_	_	_
5	basis	basis	_	_	_	_	_	_	_
6	for	for	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	unusually	unusually	_	_	_	_	_	_	_
9	persistent	persistent	_	_	_	_	_	_	_
10	transcription	transcription	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	IL-2R	IL-2R	_	_	_	_	_	_	_
14	alpha	alpha	_	_	_	_	_	_	_
15	gene	gene	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	we	we	_	_	_	_	_	_	_
18	analyzed	analyze	_	_	_	_	_	_	_
19	nuclear	nuclear	_	_	_	_	_	_	_
20	NF-kappa	NF-kappa	_	_	_	_	_	_	_
21	B	B	_	_	_	_	_	_	_
22	binding	bind	_	_	_	_	_	_	_
23	to	to	_	_	_	_	_	_	_
24	a	a	_	_	_	_	_	_	_
25	radiolabeled	radiolabele	_	_	_	_	_	_	_
26	IL-2R	il-2r	_	_	_	_	_	_	_
27	alpha	alpha	_	_	_	_	_	_	_
28	kappa	kappa	_	_	_	_	_	_	_
29	B-specific	b-specific	_	_	_	_	_	_	_
30	oligonucleotide	oligonucleotide	_	_	_	_	_	_	_
31	probe	probe	_	_	_	_	_	_	_
32	during	during	_	_	_	_	_	_	_
33	the	the	_	_	_	_	_	_	_
34	time	time	_	_	_	_	_	_	_
35	course	course	_	_	_	_	_	_	_
36	of	of	_	_	_	_	_	_	_
37	CD2	cd2	_	_	_	_	_	_	_
38	+	+	_	_	_	_	_	_	_
39	CD28	cd28	_	_	_	_	_	_	_
40	activation	activation	_	_	_	_	_	_	_
41	.	.	_	_	_	_	_	_	_

1	Resting	rest	_	_	_	_	_	_	_
2	T-cell	T-cell	_	_	_	_	_	_	_
3	nuclear	nuclear	_	_	_	_	_	_	_
4	extracts	extract	_	_	_	_	_	_	_
5	contained	contain	_	_	_	_	_	_	_
6	KBF1/p50	kbf1/p50	_	_	_	_	_	_	_
7	homodimer	homodimer	_	_	_	_	_	_	_
8	.	.	_	_	_	_	_	_	_

1	After	after	_	_	_	_	_	_	_
2	stimulation	stimulation	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	two	two	_	_	_	_	_	_	_
5	new	new	_	_	_	_	_	_	_
6	kappa	kappa	_	_	_	_	_	_	_
7	B-specific	b-specific	_	_	_	_	_	_	_
8	complexes	complex	_	_	_	_	_	_	_
9	were	be	_	_	_	_	_	_	_
10	identified	identify	_	_	_	_	_	_	_
11	as	as	_	_	_	_	_	_	_
12	NF-kappa	NF-kappa	_	_	_	_	_	_	_
13	B	B	_	_	_	_	_	_	_
14	p50-p65	p50-p65	_	_	_	_	_	_	_
15	heterodimer	heterodimer	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	putative	putative	_	_	_	_	_	_	_
18	c-Rel	c-rel	_	_	_	_	_	_	_
19	homodimer	homodimer	_	_	_	_	_	_	_
20	or	or	_	_	_	_	_	_	_
21	c-Rel-p65	c-rel-p65	_	_	_	_	_	_	_
22	heterodimer	heterodimer	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Both	both	_	_	_	_	_	_	_
2	inducible	inducible	_	_	_	_	_	_	_
3	complexes	complex	_	_	_	_	_	_	_
4	persisted	persist	_	_	_	_	_	_	_
5	for	for	_	_	_	_	_	_	_
6	at	at	_	_	_	_	_	_	_
7	least	least	_	_	_	_	_	_	_
8	3	3	_	_	_	_	_	_	_
9	weeks	week	_	_	_	_	_	_	_
10	.	.	_	_	_	_	_	_	_

1	Their	their	_	_	_	_	_	_	_
2	relative	relative	_	_	_	_	_	_	_
3	levels	level	_	_	_	_	_	_	_
4	were	be	_	_	_	_	_	_	_
5	very	very	_	_	_	_	_	_	_
6	similar	similar	_	_	_	_	_	_	_
7	for	for	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	duration	duration	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	proliferation	proliferation	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	parallel	parallel	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	CD2	cd2	_	_	_	_	_	_	_
5	+	+	_	_	_	_	_	_	_
6	CD28	cd28	_	_	_	_	_	_	_
7	activation	activation	_	_	_	_	_	_	_
8	triggered	trigger	_	_	_	_	_	_	_
9	a	a	_	_	_	_	_	_	_
10	significant	significant	_	_	_	_	_	_	_
11	intracellular	intracellular	_	_	_	_	_	_	_
12	thiol	thiol	_	_	_	_	_	_	_
13	decrease	decrease	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	suggesting	suggest	_	_	_	_	_	_	_
16	that	that	_	_	_	_	_	_	_
17	oxygen	oxygen	_	_	_	_	_	_	_
18	radicals	radical	_	_	_	_	_	_	_
19	are	be	_	_	_	_	_	_	_
20	involved	involve	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	signaling	signaling	_	_	_	_	_	_	_
24	pathway	pathway	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	adhesion	adhesion	_	_	_	_	_	_	_
27	molecules	molecule	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Finally	finally	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	micromolar	micromolar	_	_	_	_	_	_	_
4	amounts	amount	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	pyrrolidine	pyrrolidine	_	_	_	_	_	_	_
7	dithiocarbamate	dithiocarbamate	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	an	an	_	_	_	_	_	_	_
10	oxygen	oxygen	_	_	_	_	_	_	_
11	radical	radical	_	_	_	_	_	_	_
12	scavenger	scavenger	_	_	_	_	_	_	_
13	that	that	_	_	_	_	_	_	_
14	efficiently	efficiently	_	_	_	_	_	_	_
15	blocked	block	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	nuclear	nuclear	_	_	_	_	_	_	_
18	appearance	appearance	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	NF-kappa	NF-kappa	_	_	_	_	_	_	_
21	B	B	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	T-lymphocytes	T-lymphocyte	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	also	also	_	_	_	_	_	_	_
26	inhibited	inhibit	_	_	_	_	_	_	_
27	IL-2	il-2	_	_	_	_	_	_	_
28	secretion	secretion	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	IL-2R	IL-2R	_	_	_	_	_	_	_
31	alpha	alpha	_	_	_	_	_	_	_
32	cell	cell	_	_	_	_	_	_	_
33	surface	surface	_	_	_	_	_	_	_
34	expression	expression	_	_	_	_	_	_	_
35	,	,	_	_	_	_	_	_	_
36	and	and	_	_	_	_	_	_	_
37	T-cell	t-cell	_	_	_	_	_	_	_
38	proliferation	proliferation	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

1	Together	together	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	these	these	_	_	_	_	_	_	_
4	results	result	_	_	_	_	_	_	_
5	suggest	suggest	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	NF-kappa	NF-kappa	_	_	_	_	_	_	_
8	B	B	_	_	_	_	_	_	_
9	plays	play	_	_	_	_	_	_	_
10	an	an	_	_	_	_	_	_	_
11	important	important	_	_	_	_	_	_	_
12	role	role	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	long-term	long-term	_	_	_	_	_	_	_
15	activation	activation	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	human	human	_	_	_	_	_	_	_
18	primary	primary	_	_	_	_	_	_	_
19	T-lymphocytes	t-lymphocyte	_	_	_	_	_	_	_
20	via	via	_	_	_	_	_	_	_
21	CD2	cd2	_	_	_	_	_	_	_
22	+	+	_	_	_	_	_	_	_
23	CD28	cd28	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

